Delivery Order SPE2DB20D3103-SPE2DB24FP7B3
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ18M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,030.14 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FT8D7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a ceiling value of $1,310.45 and a completion date of January 17, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $10,319.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a completion date of May 19, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,164.79 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU2L6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a Delivery Order with a Firm Fixed Price, is for the supply of OPZELURA 1.5% CREAM 60GM, with a total ceiling value of $3,850.30 and a completion date of May 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,773.89 firm fixed price delivery order is for the supply of OPZELURA 1.5% cream in a 60 gram quantity, with a completion date of May 29, 2025. The contract is not designated as a set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,429.17 Firm Fixed Price Delivery Order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,955.54 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, to support various government agency healthcare programs. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FADA7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,934.06, is for the delivery of OPZELURA 1.5% Cream (60 gm) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, SPE2DB22D3016|SPE2DB24FBAQ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,419.26 Firm Fixed Price contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...